WO2006083260A3 - Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use - Google Patents
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use Download PDFInfo
- Publication number
- WO2006083260A3 WO2006083260A3 PCT/US2005/014906 US2005014906W WO2006083260A3 WO 2006083260 A3 WO2006083260 A3 WO 2006083260A3 US 2005014906 W US2005014906 W US 2005014906W WO 2006083260 A3 WO2006083260 A3 WO 2006083260A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- groups
- preparation
- systems
- associated methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ550964A NZ550964A (en) | 2004-04-28 | 2005-04-28 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
KR1020067025027A KR100974733B1 (en) | 2004-04-28 | 2005-04-28 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
KR1020107011113A KR101148445B1 (en) | 2004-04-28 | 2005-04-28 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
BRPI0510477-7A BRPI0510477B1 (en) | 2004-04-28 | 2005-04-28 | METHOD FOR FORMING A GEL AND DEVICE FOR USE IN MEDICAL APPLICATIONS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56656904P | 2004-04-28 | 2004-04-28 | |
US60/566,569 | 2004-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006083260A2 WO2006083260A2 (en) | 2006-08-10 |
WO2006083260A3 true WO2006083260A3 (en) | 2009-02-26 |
Family
ID=36692662
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/015036 WO2006078282A2 (en) | 2004-04-28 | 2005-04-28 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
PCT/US2005/014906 WO2006083260A2 (en) | 2004-04-28 | 2005-04-28 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/015036 WO2006078282A2 (en) | 2004-04-28 | 2005-04-28 | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
Country Status (7)
Country | Link |
---|---|
US (3) | US8067031B2 (en) |
KR (2) | KR101148445B1 (en) |
CN (2) | CN104174071A (en) |
BR (1) | BRPI0510477B1 (en) |
HK (1) | HK1204584A1 (en) |
NZ (1) | NZ550964A (en) |
WO (2) | WO2006078282A2 (en) |
Families Citing this family (181)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
US6702744B2 (en) | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
US7361368B2 (en) | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
US20090165784A1 (en) * | 2007-12-28 | 2009-07-02 | Tyco Healthcare Group Lp | Lubricious intubation device |
US7641643B2 (en) | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
AU2004322006B2 (en) * | 2004-07-31 | 2012-05-24 | Brainguard Co., Ltd. | Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
CA2577025C (en) * | 2004-08-13 | 2014-01-28 | Ottawa Health Research Institute | Vision enhancing ophthalmic devices and related methods and compositions |
US7854944B2 (en) | 2004-12-17 | 2010-12-21 | Advanced Cardiovascular Systems, Inc. | Tissue regeneration |
US8303972B2 (en) | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
CA2607913C (en) * | 2005-05-05 | 2014-03-18 | Cook Biotech Incorporated | Implantable materials and methods for inhibiting tissue adhesion formation |
US20060287257A1 (en) * | 2005-06-20 | 2006-12-21 | Stockel Richard F | Pharmaceutical compositions to treat diseases caused by mycobacterium |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
AU2006291134C1 (en) | 2005-09-12 | 2013-08-15 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same |
WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
JP5178520B2 (en) | 2005-09-22 | 2013-04-10 | メディバス エルエルシー | Solid polymer delivery compositions and methods of use thereof |
EP1926780B1 (en) | 2005-09-22 | 2013-08-14 | Medivas, LLC | Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use |
CN100387711C (en) * | 2006-01-06 | 2008-05-14 | 青岛科技大学 | Silica-gel-carrier surface macroporous chitin substrate for lysozyme affinity chromatography |
US20090038701A1 (en) | 2006-01-17 | 2009-02-12 | Baxter International Inc. | Device, system and method for mixing |
US20090319044A1 (en) * | 2006-01-31 | 2009-12-24 | Francis Young-In Lee | Methods and Compositions for Improving the Incorporation of Orthopaedic and Orthodontic Implants |
US20070270970A1 (en) * | 2006-03-14 | 2007-11-22 | Sdgi Holdings, Inc. | Spinal implants with improved wear resistance |
US20070233246A1 (en) * | 2006-03-31 | 2007-10-04 | Sdgi Holdings, Inc. | Spinal implants with improved mechanical response |
WO2007139808A2 (en) * | 2006-05-25 | 2007-12-06 | Ayyala Ramesh S | Device for delivery of antifibrotic agents & method |
KR101443926B1 (en) | 2006-06-15 | 2014-10-02 | 마이크로벤션, 인코포레이티드 | Embolization device constructed from expansible polymer |
US7732190B2 (en) | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
TWI436793B (en) | 2006-08-02 | 2014-05-11 | Baxter Int | Rapidly acting dry sealant and methods for use and manufacture |
DE102006037158A1 (en) * | 2006-08-02 | 2008-02-14 | Bioxsys Gmbh | Method for determining the sensitivity of tumors to capecitabine and test kit |
US20080039362A1 (en) * | 2006-08-09 | 2008-02-14 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
WO2008034908A2 (en) * | 2006-09-22 | 2008-03-27 | Bioxell Spa | Use of vitamin d compounds for the prevention of adhesions |
US20080078412A1 (en) * | 2006-10-03 | 2008-04-03 | Restore Medical, Inc. | Tongue implant |
US20080078411A1 (en) * | 2006-10-03 | 2008-04-03 | Restore Medical, Inc. | Tongue implant for sleep apnea |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
WO2008076383A2 (en) | 2006-12-18 | 2008-06-26 | Med Institute Inc. | Stent graft with releasable therapeutic agent |
US20080226724A1 (en) * | 2007-01-19 | 2008-09-18 | Genentech, Inc. | Prevention of hydrogel viscosity loss |
US8262608B2 (en) * | 2007-01-25 | 2012-09-11 | Hyperbranch Medical Technology, Inc. | Applicators for multiple component formulations and the like, and methods of use thereof |
US20080188932A1 (en) * | 2007-02-07 | 2008-08-07 | Harrup Mason K | Coated medical implants, methods of coating medical implants, and methods of coating materials |
US8591931B2 (en) * | 2007-02-14 | 2013-11-26 | Shangdong Intech Medical Technology Co., Ltd | Coronary stent with asymmetric drug releasing controlled coating |
US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
US20080255041A1 (en) * | 2007-04-11 | 2008-10-16 | Ebi, L.P. | Treatment of annulus fibrosis defects |
US20080287633A1 (en) * | 2007-05-18 | 2008-11-20 | Drumheller Paul D | Hydrogel Materials |
CA2693969A1 (en) * | 2007-07-17 | 2009-01-22 | Medivas, Llc | Bioabsorbable elastomeric arterial support device and methods of use |
WO2009052376A1 (en) | 2007-10-18 | 2009-04-23 | Musc Foundation For Research Development | Methods for the diagnosis of genitourinary cancer |
US8361052B2 (en) * | 2007-10-30 | 2013-01-29 | Uti Limited Partnership | Method and system for sustained-release of sclerosing agent |
US20090117039A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Charged biodegradable polymers for medical applications |
US20130142733A1 (en) * | 2007-11-05 | 2013-06-06 | Vanderbilt University | Multifunctional degradable nanoparticles with control over size and functionalities |
US11254786B2 (en) | 2007-11-05 | 2022-02-22 | Vanderbilt University | Multifunctional degradable nanoparticles with control over size and functionalities |
US20110244006A1 (en) * | 2007-11-29 | 2011-10-06 | The Trustees Of Columbia University In The City Of New York | Microsphere skin treatment |
US20110027379A1 (en) * | 2007-12-06 | 2011-02-03 | Cornell University | Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use |
CA2709581C (en) * | 2007-12-17 | 2013-06-11 | Anna Love | Soft tissue filler |
US8299316B2 (en) * | 2007-12-18 | 2012-10-30 | Ethicon, Inc. | Hemostatic device |
US8470035B2 (en) | 2007-12-21 | 2013-06-25 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
JP5530934B2 (en) | 2008-01-24 | 2014-06-25 | ユニバーシティ オブ ユタ リサーチ ファンデーション | Adhesive composite coacervate and methods of making and using the same |
US8283384B2 (en) | 2008-01-24 | 2012-10-09 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
JP2011526818A (en) * | 2008-07-03 | 2011-10-20 | ヴェッセルテック バイオメディカル,エルエルシー | Controlled local release of retinoids to improve neointimal hyperplasia |
US8207264B2 (en) * | 2008-07-11 | 2012-06-26 | Tyco Healthcare Group Lp | Functionalized inclusion complexes as crosslinkers |
US8603532B2 (en) | 2008-10-20 | 2013-12-10 | Massachusetts Institute Of Technology | Nanostructures for drug delivery |
BRPI0921494A2 (en) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | method of planning a underground forming sampling operation, method of controlling a underground forming sampling operation, method of controlling a drilling operation for an underground formation, and method of sampling during the drilling operation. |
US9234100B2 (en) | 2009-02-20 | 2016-01-12 | Uniboard Canada Inc. | Chitosan-based adhesives and uses thereof |
US9250106B2 (en) | 2009-02-27 | 2016-02-02 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
AU2010217760B2 (en) | 2009-02-27 | 2015-04-09 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
GB0912855D0 (en) * | 2009-07-23 | 2009-08-26 | Orthogem Ltd | Composite delivery device |
CA2769030C (en) | 2009-07-30 | 2016-05-10 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
BR112012009287A2 (en) | 2009-10-26 | 2017-06-06 | Microvention Inc | embolization device made of expandable polymer |
EP2493314B1 (en) | 2009-10-30 | 2020-04-08 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis |
WO2011066471A1 (en) | 2009-11-25 | 2011-06-03 | Loma Linda University Medical Center | Chitosan-based hemostatic textile |
CN102791294A (en) * | 2009-12-16 | 2012-11-21 | 布里格姆妇女医院股份有限公司 | Particles for multiple agent delivery |
EP2538929A4 (en) | 2010-02-25 | 2014-07-09 | Univ Johns Hopkins | Sustained delivery of therapeutic agents to an eye compartment |
AU2011232343B2 (en) * | 2010-03-25 | 2015-05-07 | Covidien Lp | Chemical knots for sutures |
AU2011232356B2 (en) | 2010-03-25 | 2015-02-05 | Covidien Lp | Functionalized adhesive for medical devices |
US10987093B2 (en) * | 2010-04-05 | 2021-04-27 | Neomend, Inc. | Method and apparatus for wound sealant application |
SA111320355B1 (en) * | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | Hemostatic sponge |
US9801738B2 (en) * | 2010-04-14 | 2017-10-31 | Northwestern University | Liquid cast biodegradable arterial stent |
WO2011140519A2 (en) | 2010-05-07 | 2011-11-10 | Medicus Biosciences, Llc | In vivo gelling pharmaceutical pre-formulation |
US8697111B2 (en) | 2010-05-12 | 2014-04-15 | Covidien Lp | Osteochondral implant comprising osseous phase and chondral phase |
EP2575906B1 (en) | 2010-05-24 | 2014-12-10 | University of Utah Research Foundation | Reinforced adhesive complex coacervates and methods of making and using thereof |
CA2812599A1 (en) | 2010-11-12 | 2012-05-18 | University Of Utah Research Foundation | Simple adhesive coacervates and methods of making and using thereof |
US8551525B2 (en) | 2010-12-23 | 2013-10-08 | Biostructures, Llc | Bone graft materials and methods |
US9770527B2 (en) | 2011-01-04 | 2017-09-26 | Bender Analytical Holding B.V. | Cross-linked polymers and implants derived from electrophilically activated polyoxazoline |
WO2012106317A1 (en) | 2011-01-31 | 2012-08-09 | Northwestern University | Injectable thermoresponsive polyelectrolytes |
US9327037B2 (en) | 2011-02-08 | 2016-05-03 | The Johns Hopkins University | Mucus penetrating gene carriers |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
JP6045575B2 (en) | 2011-06-23 | 2016-12-14 | ディーエスエム アイピー アセッツ ビー.ブイ. | Novel biodegradable polyesteramide copolymers for drug delivery |
CN103732330A (en) * | 2011-06-28 | 2014-04-16 | 犹他大学研究基金会 | Adhesive complex coacervates and methods of making and using thereof |
US11083821B2 (en) | 2011-08-10 | 2021-08-10 | C.P. Medical Corporation | Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules |
US10111985B2 (en) | 2011-08-10 | 2018-10-30 | Medicus Biosciences, Llc | Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules |
JP6159973B2 (en) | 2012-01-02 | 2017-07-12 | ユニヴェルシテイト ヘントUniversiteit Gent | Polyoxazoline polymers and methods for their production, conjugates of these polymers and their medical use |
KR101401632B1 (en) | 2012-02-20 | 2014-06-03 | 주식회사 제노스 | Baloon carteter and method for producing the same |
US20150037422A1 (en) * | 2012-02-22 | 2015-02-05 | Trustees Of Tufts College | Compositions and methods for ocular delivery of a therapeutic agent |
US8851173B2 (en) | 2012-03-09 | 2014-10-07 | Halliburton Energy Services, Inc. | Set-delayed cement compositions comprising pumice and associated methods |
US9790132B2 (en) | 2012-03-09 | 2017-10-17 | Halliburton Energy Services, Inc. | Set-delayed cement compositions comprising pumice and associated methods |
US10202751B2 (en) | 2012-03-09 | 2019-02-12 | Halliburton Energy Services, Inc. | Set-delayed cement compositions comprising pumice and associated methods |
US10195764B2 (en) | 2012-03-09 | 2019-02-05 | Halliburton Energy Services, Inc. | Set-delayed cement compositions comprising pumice and associated methods |
JP6178399B2 (en) * | 2012-03-16 | 2017-08-09 | ベンデル アナリティカル ホールディング ビー.ブイ.Bender Analytical Holding B.V. | Crosslinked polymers derived from nucleophilically activated polyoxazolines and medical products |
CA2867381C (en) | 2012-03-16 | 2016-09-20 | The Johns Hopkins University | Controlled release formulations for the delivery of hif-1 inhibitors |
EA030318B1 (en) | 2012-03-16 | 2018-07-31 | Дзе Джонс Хопкинс Юниверсити | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
US9533068B2 (en) | 2012-05-04 | 2017-01-03 | The Johns Hopkins University | Drug loaded microfiber sutures for ophthalmic application |
CA2873105C (en) | 2012-05-11 | 2018-01-16 | Medicus Biosciences, Llc | Biocompatible hydrogel treatments for retinal detachment |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9132171B2 (en) | 2012-05-23 | 2015-09-15 | Wisconsin Alumni Research Foundation | Test of insulin as a drug to reduce restenosis of vessels |
NL2008861C2 (en) * | 2012-05-23 | 2013-11-26 | Urogyn B V | Composition for soft tissue treatment. |
US9351993B2 (en) | 2012-06-14 | 2016-05-31 | Microvention, Inc. | Polymeric treatment compositions |
WO2014022807A2 (en) * | 2012-08-03 | 2014-02-06 | Alumend, Llc | Compositions and methods of using the compositions for plaque softening |
AU2013331439B2 (en) | 2012-10-15 | 2016-05-12 | Microvention, Inc. | Polymeric treatment compositions |
US9220807B2 (en) * | 2012-11-04 | 2015-12-29 | Miba Medical Inc. | Non-toxic cross-linker for hyaluronic acid |
EP3013354B1 (en) * | 2013-01-16 | 2020-08-19 | Alumend, LLC | Composition for decreasing inflammatory response in a blood vessel |
US20140212355A1 (en) | 2013-01-28 | 2014-07-31 | Abbott Cardiovascular Systems Inc. | Trans-arterial drug delivery |
US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
WO2014123665A1 (en) | 2013-02-06 | 2014-08-14 | Kci Licensing, Inc. | Polymers, preparation and use thereof |
ES2678875T3 (en) | 2013-03-04 | 2018-08-20 | DERMELLE, LLC d/b/a ETERNOGEN, LLC | In situ polymerization collagen composition for injection |
AU2014236385B2 (en) | 2013-03-14 | 2019-01-24 | Theragenics Corporation | Biocompatible hydrogel polymer matrix for delivery of cells |
US10624865B2 (en) | 2013-03-14 | 2020-04-21 | Pathak Holdings Llc | Methods, compositions, and devices for drug/live cell microarrays |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10188824B2 (en) * | 2013-05-13 | 2019-01-29 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Aerostasis in pulmonary surgery |
JP2017503017A (en) * | 2013-12-18 | 2017-01-26 | ウィンドギャップ メディカル, インコーポレイテッド | Drug mixing and delivery system and method |
US9682218B2 (en) | 2013-12-23 | 2017-06-20 | Carefusion 2200, Inc. | Pleurodesis device and method |
US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
US9259357B2 (en) | 2014-04-16 | 2016-02-16 | Loma Linda University | Composition, preparation, and use of chitosan shards for biomedical applications |
WO2015167751A1 (en) | 2014-04-29 | 2015-11-05 | Microvention, Inc. | Polymers |
EP3137124B1 (en) | 2014-04-29 | 2019-01-09 | Microvention, Inc. | Polymers including active agents |
US10022475B2 (en) * | 2014-05-01 | 2018-07-17 | Bao Tran | Body augmentation device |
US9913927B2 (en) | 2014-07-14 | 2018-03-13 | University Of Utah Research Foundation | In situ solidifying complex coacervates and methods of making and using thereof |
CA2954191A1 (en) * | 2014-07-30 | 2016-02-04 | Lifecell Corporation | Methods for selection of age-appropriate tissues |
AU2015328825B2 (en) | 2014-10-06 | 2019-02-21 | Gatt Technologies B.V. | Tissue-adhesive porous haemostatic product |
AU2015364280A1 (en) | 2014-12-18 | 2017-07-06 | Windgap Medical, Inc. | Method and compositions for dissolving or solubilizing therapeutic agents |
JP6720447B2 (en) | 2014-12-18 | 2020-07-08 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Drug delivery system for delivery of acid sensitive drugs |
CN105561404B (en) * | 2015-01-07 | 2019-07-26 | 北京赛奇科科技有限公司 | A kind of medical material and preparation method thereof to prevent adhesion for gynemetrics |
CA2974715C (en) | 2015-01-27 | 2020-05-05 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
CN106264777A (en) * | 2015-06-08 | 2017-01-04 | 三鼎生物科技股份有限公司 | Auxiliary dacryagogue |
US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
WO2018106777A1 (en) | 2016-12-07 | 2018-06-14 | Henkel IP & Holding GmbH | Syringe with piston assembly |
CN110381854A (en) * | 2017-01-05 | 2019-10-25 | 考恩特兰有限公司 | Method for being implanted into and reversing stimulating responsive implantation material |
US10912859B2 (en) | 2017-03-08 | 2021-02-09 | Baxter International Inc. | Additive able to provide underwater adhesion |
US11202848B2 (en) | 2017-03-08 | 2021-12-21 | Baxter International Inc. | Surgical adhesive able to glue in wet conditions |
WO2019074965A1 (en) | 2017-10-09 | 2019-04-18 | Microvention, Inc. | Radioactive liquid embolic |
US10709815B2 (en) * | 2017-10-16 | 2020-07-14 | Kent State University | Biodegradable, biocompatible 3D liquid crystal elastomeric foam scaffolds having tailor-made animal (human) pore cell sizes via a salt leaching method are capable of growing tissue therein for therapeutic reconstruction of damaged and/or diseased tissue or organs |
KR101989054B1 (en) * | 2017-11-28 | 2019-06-13 | (주)다림티센 | Hemostatic agent and container containing the same |
US11896234B2 (en) | 2018-01-26 | 2024-02-13 | Fluidx Medical Technology, Llc | Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion |
CN108211909B (en) * | 2018-03-05 | 2024-02-06 | 常城 | Dyeing paste mixing device for dyeing hair and dyeing method thereof capable of keeping dyeing consistency |
CN108744060B (en) * | 2018-05-29 | 2021-05-07 | 四川大学 | Bone repair material capable of being injected with multiple pore structures and preparation method thereof |
CN109045354B (en) * | 2018-07-26 | 2020-12-08 | 华中科技大学 | In-situ forming injectable hydrogel for comprehensive repair of bone-cartilage |
CN112957516B (en) * | 2018-08-20 | 2022-08-09 | 稳得希林(杭州)生物科技有限公司 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
EP3920894A4 (en) * | 2019-02-06 | 2022-11-09 | The University of North Carolina at Chapel Hill | Compositions and methods for inhibiting post-surgical adhesions |
EP3934659A4 (en) * | 2019-03-05 | 2022-12-14 | Medcura, Inc. | System and method to reduce tissue or organ adhesion |
CN114072163A (en) * | 2019-05-09 | 2022-02-18 | 芝加哥大学 | New material for healing skin wound and preventing scar |
US11753382B2 (en) | 2019-06-25 | 2023-09-12 | Translatum Medicus Inc. | Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives |
BR112022000511A2 (en) * | 2019-07-12 | 2022-03-03 | Gatt Tech B V | Biocompatible flexible hemostatic sheet, sealed packaging and homeostatic sheet preparation method |
CN110540404B (en) * | 2019-10-17 | 2022-06-10 | 广州润虹医药科技股份有限公司 | Calcium phosphate bone cement with hollow through structure, preparation method and application thereof |
CN112730015B (en) * | 2019-10-28 | 2022-11-22 | 上海云泽生物科技有限公司 | Dilution for stabilizing tacrolimus and application thereof |
EP4100072A1 (en) * | 2020-02-04 | 2022-12-14 | Boston Scientific Scimed Inc. | Injectable in vivo crosslinking materials for use as soft tissue fillers |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
SE2050826A1 (en) * | 2020-07-02 | 2022-01-03 | Capitainer Ab | Functionalized blood sampling device and method for peth measurement |
CN112129946A (en) * | 2020-08-16 | 2020-12-25 | 陆修委 | Preparation method and application of sugar-free chain type inert protein sealant |
US11339045B2 (en) | 2020-10-20 | 2022-05-24 | Elkay Manufacturing Company | Flavor and additive delivery systems and methods for beverage dispensers |
US20240033399A1 (en) * | 2020-12-18 | 2024-02-01 | Ethicon, Inc. | Methods and Devices for Changing the Flow Rates of PH Modifying Fluids for Controlling Cross-Linking Rates of Reactive Components of Biocompatible Sealing Compositions |
CN112705054B (en) * | 2020-12-24 | 2022-06-24 | 健帆生物科技集团股份有限公司 | Hollow fiber membrane, preparation method thereof and dialyzer |
CN113018461B (en) * | 2021-03-09 | 2022-07-26 | 南京邮电大学 | Fucoidin embolism microsphere capable of magnetic resonance imaging and preparation method thereof |
EP4252787A1 (en) * | 2021-04-14 | 2023-10-04 | Beijing Biosis Healing Biological Technology Co., Ltd. | Medical hydrogel and preparation method therefor and use thereof |
CN113101039B (en) * | 2021-04-26 | 2022-10-18 | 金浙滔 | Oviduct contraceptive device, implanting device and extracting device |
CN113416292B (en) * | 2021-04-30 | 2022-07-19 | 山东师范大学 | Hydrogel capable of loading high-hydrophobicity drugs and preparation method and application thereof |
CN113846054B (en) * | 2021-09-23 | 2023-05-16 | 四川大学 | Matrix material for directly reprogramming fibroblast into osteoblast, preparation method and reprogramming method |
CN114099784B (en) * | 2021-10-26 | 2022-09-16 | 四川兴科蓉药业有限责任公司 | Injection type skin filling composition and preparation method and application thereof |
WO2024042535A1 (en) * | 2022-08-20 | 2024-02-29 | Jawaharlal Nehru Centre For Advanced Scientific Research | Hemostatic composite, its method and applications thereof |
CN115403723B (en) * | 2022-08-24 | 2023-10-13 | 中原工学院 | Preparation method and application of lithium anode modified based on covalent organic framework material |
CN116448996B (en) * | 2023-03-22 | 2023-11-21 | 卡秋(江苏)生物科技有限公司 | Preparation method of polymerase-antibody complex with bead structure |
CN116570757B (en) * | 2023-07-05 | 2023-10-03 | 北京镧系生物科技有限公司 | Double-component in-situ adhesive based on super-charged protein, and preparation method and application thereof |
CN117504137B (en) * | 2024-01-05 | 2024-03-12 | 山东瑞安泰医疗技术有限公司 | Cardiac pacemaker fixing device and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010003126A1 (en) * | 1995-10-05 | 2001-06-07 | Rhee Woonza M. | Method of making crosslinked polymer matrices in tissue treatment applications |
WO2002102864A1 (en) * | 2001-06-15 | 2002-12-27 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
WO2003080144A1 (en) * | 2002-03-22 | 2003-10-02 | Kuros Biosurgery Ag | Composition for hard tissue augmentation |
Family Cites Families (194)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3091542A (en) | 1960-09-20 | 1963-05-28 | Dow Chemical Co | Insolubilization of water-soluble cellulose ethers |
NL126192C (en) | 1964-07-16 | |||
US3619371A (en) | 1967-07-03 | 1971-11-09 | Nat Res Dev | Production of a polymeric matrix having a biologically active substance bound thereto |
SE343210B (en) | 1967-12-20 | 1972-03-06 | Pharmacia Ab | |
US4008341A (en) * | 1968-10-11 | 1977-02-15 | W. R. Grace & Co. | Curable liquid polymer compositions |
US3742955A (en) | 1970-09-29 | 1973-07-03 | Fmc Corp | Fibrous collagen derived product having hemostatic and wound binding properties |
US3810473A (en) | 1972-12-04 | 1974-05-14 | Avicon Inc | Liquid-laid, non-woven, fibrous collagen derived surgical web having hemostatic and wound sealing properties |
US3876501A (en) | 1973-05-17 | 1975-04-08 | Baxter Laboratories Inc | Binding enzymes to activated water-soluble carbohydrates |
GB1479268A (en) | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
DE2360794C2 (en) | 1973-12-06 | 1984-12-06 | Hoechst Ag, 6230 Frankfurt | Process for the production of peptides |
US3949073A (en) | 1974-11-18 | 1976-04-06 | The Board Of Trustees Of Leland Stanford Junior University | Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution |
CH596313A5 (en) | 1975-05-30 | 1978-03-15 | Battelle Memorial Institute | |
US4237229A (en) * | 1975-06-10 | 1980-12-02 | W. R. Grace & Co. | Immobilization of biological material with polyurethane polymers |
IL47468A (en) | 1975-06-12 | 1979-05-31 | Rehovot Res Prod | Process for the cross-linking of proteins using water soluble cross-linking agents |
US4488911A (en) | 1975-10-22 | 1984-12-18 | Luck Edward E | Non-antigenic collagen and articles of manufacture |
US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
NL7704659A (en) | 1976-05-12 | 1977-11-15 | Battelle Institut E V | BONE REPLACEMENT, BONE JOINT, OR PROSTHESIS ANCHORING MATERIAL. |
GB1578348A (en) | 1976-08-17 | 1980-11-05 | Pharmacia Ab | Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic |
SE431758B (en) * | 1977-03-04 | 1984-02-27 | Pharmacia Fine Chemicals Ab | AS THE USE OF THE TIOLATION REAGENT OR BERRY MATRIX FOR ENZYMERS DERIVATIVE OF A SH GROUPING POLYMER |
CH628074A5 (en) | 1977-03-10 | 1982-02-15 | Ciba Geigy Ag | HARDENABLE MIXTURES BASED ON EPOXY COMPOUNDS. |
US4164559A (en) | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
US4404970A (en) | 1978-05-19 | 1983-09-20 | Sawyer Philip Nicholas | Hemostatic article and methods for preparing and employing the same |
US4390519A (en) | 1978-05-19 | 1983-06-28 | Sawyer Philip Nicholas | Bandage with hemostatic agent and methods for preparing and employing the same |
US4238480A (en) | 1978-05-19 | 1980-12-09 | Sawyer Philip Nicholas | Method for preparing an improved hemostatic agent and method of employing the same |
FR2449610A1 (en) | 1979-01-02 | 1980-09-19 | Remy Ets Pierre | INVIOLABLE STOPPING PROCESS FOR SCREW BOTTLE |
JPS6023084B2 (en) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | blood substitute |
US4412947A (en) | 1979-09-12 | 1983-11-01 | Seton Company | Collagen sponge |
US4279812A (en) | 1979-09-12 | 1981-07-21 | Seton Company | Process for preparing macromolecular biologically active collagen |
DE2943520C2 (en) | 1979-10-27 | 1982-05-19 | Fa. Carl Freudenberg, 6940 Weinheim | Process for the production of collagen sponge for medical or cosmetic purposes |
US4378017A (en) | 1980-03-21 | 1983-03-29 | Kureha Kagaku Kogyo Kabushiki Kaisha | Composite material of de-N-acetylated chitin and fibrous collagen |
CS216992B1 (en) | 1980-07-21 | 1982-12-31 | Miroslav Stol | Composite polymere material for the biological and medicinal utilitation and method of preparation thereof |
US4314380A (en) | 1980-09-26 | 1982-02-09 | Koken Co., Ltd. | Artificial bone |
US4415665A (en) | 1980-12-12 | 1983-11-15 | Pharmacia Fine Chemicals Ab | Method of covalently binding biologically active organic substances to polymeric substances |
US4414147A (en) | 1981-04-17 | 1983-11-08 | Massachusetts Institute Of Technology | Methods of decreasing the hydrophobicity of fibroblast and other interferons |
JPS57206622A (en) | 1981-06-10 | 1982-12-18 | Ajinomoto Co Inc | Blood substitute |
EP0067671B1 (en) * | 1981-06-12 | 1989-11-15 | National Research Development Corporation | Hydrogels |
US4451568A (en) | 1981-07-13 | 1984-05-29 | Battelle Memorial Institute | Composition for binding bioactive substances |
US4357274A (en) | 1981-08-06 | 1982-11-02 | Intermedicat Gmbh | Process for the manufacture of sclero protein transplants with increased biological stability |
US4415628A (en) | 1981-10-26 | 1983-11-15 | Seton Company | Moisture vapor permeable sheet materials |
JPS5896026A (en) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | Novel urokinase derivative, its preparation and thrombolytic agent containing the same |
FR2517315B1 (en) | 1981-11-30 | 1985-12-20 | Tech Cuir Centre | PROCESS FOR THE PREPARATION OF NEW FORMS OF COLLAGEN, NATIVE OR DERETICULATED, WITH PRESERVED HELICOIDAL STRUCTURE, ASSOCIATED WITH MUCOPOLYSACCHARIDES AND THEIR APPLICATIONS IN PARTICULAR IN THE COSMETOLOGICAL, PHARMACEUTICAL, ANALYTICAL AND OTHER FIELDS |
US4424208A (en) | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4578067A (en) | 1982-04-12 | 1986-03-25 | Alcon (Puerto Rico) Inc. | Hemostatic-adhesive, collagen dressing for severed biological surfaces |
JPS58180162A (en) | 1982-04-19 | 1983-10-21 | 株式会社高研 | Anti-thrombosis medical material |
US4461298A (en) * | 1982-07-26 | 1984-07-24 | Ethicon, Inc. | Composite sutures of silk and hydrophobic thermoplastic elastomers |
US4544516A (en) | 1982-07-28 | 1985-10-01 | Battelle Development Corporation | Collagen orientation |
US4737544A (en) | 1982-08-12 | 1988-04-12 | Biospecific Technologies, Inc. | Biospecific polymers |
US4973493A (en) | 1982-09-29 | 1990-11-27 | Bio-Metric Systems, Inc. | Method of improving the biocompatibility of solid surfaces |
JPS6028936A (en) | 1983-07-27 | 1985-02-14 | Koken:Kk | Atherocollagen aqueous solution and its preparation |
US4563351A (en) | 1983-08-01 | 1986-01-07 | Forsyth Dental Infirmary For Children | Self-gelling therapeutic compositions for topical application |
US4448718A (en) | 1983-09-13 | 1984-05-15 | Massachusetts Institute Of Technology | Method for the preparation of collagen-glycosaminoglycan composite materials |
US4515637A (en) | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
US4487865A (en) | 1983-12-15 | 1984-12-11 | Biomatrix, Inc. | Polymeric articles modified with hyaluronate |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
MX163953B (en) | 1984-03-27 | 1992-07-03 | Univ New Jersey Med | PROCEDURE FOR PREPARING A BIODEGRADABLE COLLAGEN MATRIX |
US4789663A (en) | 1984-07-06 | 1988-12-06 | Collagen Corporation | Methods of bone repair using collagen |
JPS6145765A (en) | 1984-08-07 | 1986-03-05 | 宇部興産株式会社 | Blood vessel prosthesis and its production |
US4553974A (en) | 1984-08-14 | 1985-11-19 | Mayo Foundation | Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor |
US4687820A (en) | 1984-08-22 | 1987-08-18 | Cuno Incorporated | Modified polypeptide supports |
US4557764A (en) | 1984-09-05 | 1985-12-10 | Collagen Corporation | Process for preparing malleable collagen and the product thereof |
US4563350A (en) | 1984-10-24 | 1986-01-07 | Collagen Corporation | Inductive collagen based bone repair preparations |
US4888366A (en) | 1984-10-24 | 1989-12-19 | Collagen Corporation | Inductive collagen-based bone repair preparations |
GB8430252D0 (en) | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
US4582865A (en) | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US5128326A (en) | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
US4600533A (en) | 1984-12-24 | 1986-07-15 | Collagen Corporation | Collagen membranes for medical use |
US4732863A (en) | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
US4636526A (en) | 1985-02-19 | 1987-01-13 | The Dow Chemical Company | Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics |
US4695602A (en) | 1985-02-28 | 1987-09-22 | Lnp Corporation | Fiber reinforced thermoplastics containing silicone interpenetrating polymer networks |
US4839345A (en) * | 1985-03-09 | 1989-06-13 | Nippon Oil And Fats Co., Ltd. | Hydrated adhesive gel and method for preparing the same |
US5099013A (en) | 1985-03-12 | 1992-03-24 | Biomatrix, Inc, | Hylan preparation and method of recovery thereof from animal tissues |
US4642117A (en) | 1985-03-22 | 1987-02-10 | Collagen Corporation | Mechanically sheared collagen implant material and method |
CA1260391A (en) | 1985-03-28 | 1989-09-26 | Karl A. Piez | Xenogeneic collagen/mineral preparations in bone repair |
DE3521684A1 (en) | 1985-06-18 | 1986-12-18 | Dr. Müller-Lierheim KG, Biologische Laboratorien, 8033 Planegg | METHOD FOR COATING POLYMERS |
DE3675588D1 (en) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE). |
US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US5202431A (en) | 1985-07-08 | 1993-04-13 | Fidia, S.P.A. | Partial esters of hyaluronic acid |
US4851513A (en) | 1985-09-06 | 1989-07-25 | Minnesota Mining And Manufacturing Company | Viscoelastic collagen solution for opthalmic use and method of preparation |
JPS63502354A (en) | 1986-01-06 | 1988-09-08 | ザ ユニヴァーシティ オブ メルボルン | collagen products |
US4774227A (en) | 1986-02-14 | 1988-09-27 | Collagen Corporation | Collagen compositions for bone repair containing autogeneic marrow |
US4983580A (en) | 1986-04-04 | 1991-01-08 | Allergan, Inc. | Methods and materials for use in corneal wound healing |
ES2004281A6 (en) | 1986-04-04 | 1988-12-16 | Univ Jefferson | Method of treating a synthetic naturally occurring surface with a collagen laminate to support microvascular endothelial cell growth, and the surface itself |
US4745180A (en) | 1986-06-27 | 1988-05-17 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using heparin fragments |
US4979959A (en) | 1986-10-17 | 1990-12-25 | Bio-Metric Systems, Inc. | Biocompatible coating for solid surfaces |
US4865602A (en) | 1986-11-06 | 1989-09-12 | Collagen Corporation | Gamma irradiation of collagen/mineral mixtures |
FR2616318A1 (en) | 1987-06-15 | 1988-12-16 | Centre Nat Rech Scient | ARTIFICIAL SKIN AND PROCESS FOR PREPARING THE SAME |
US4829099A (en) * | 1987-07-17 | 1989-05-09 | Bioresearch, Inc. | Metabolically acceptable polyisocyanate adhesives |
US6030958A (en) * | 1987-09-18 | 2000-02-29 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US6235726B1 (en) * | 1987-09-18 | 2001-05-22 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
US4937270A (en) | 1987-09-18 | 1990-06-26 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
US5017229A (en) | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US5364622A (en) | 1987-12-04 | 1994-11-15 | Dr. Karl Thomae Gmbh | Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel |
US4886866A (en) * | 1987-12-21 | 1989-12-12 | W. R. Grace & Co.-Conn. | Contact lenses based on biocompatible polyurethane and polyurea-urethane hydrated polymers |
US4950699A (en) | 1988-01-11 | 1990-08-21 | Genetic Laboratories, Inc. | Wound dressing incorporating collagen in adhesive layer |
US4847325A (en) | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US5192316A (en) | 1988-02-16 | 1993-03-09 | Allergan, Inc. | Ocular device |
US5024742A (en) | 1988-02-24 | 1991-06-18 | Cedars-Sinai Medical Center | Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers |
US4923467A (en) | 1988-03-02 | 1990-05-08 | Thompson Keith P | Apparatus and process for application and adjustable reprofiling of synthetic lenticules for vision correction |
US5156622A (en) | 1988-03-02 | 1992-10-20 | Thompson Keith P | Apparatus and process for application and adjustable reprofiling of synthetic lenticules for vision correction |
FR2628634B1 (en) | 1988-03-15 | 1990-07-13 | Imedex | VISCERAL SURGERY PATCH |
JPH01265970A (en) | 1988-04-19 | 1989-10-24 | Shiseido Co Ltd | Collagen water solution or water dispersion solution including hyaluronic acid |
US5290552A (en) | 1988-05-02 | 1994-03-01 | Matrix Pharmaceutical, Inc./Project Hear | Surgical adhesive material |
US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5167960A (en) | 1988-08-03 | 1992-12-01 | New England Deaconess Hospital Corporation | Hirudin-coated biocompatible substance |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5527856A (en) * | 1988-11-21 | 1996-06-18 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
US5306500A (en) | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
US5614587A (en) | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US5264214A (en) | 1988-11-21 | 1993-11-23 | Collagen Corporation | Composition for bone repair |
US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5936035A (en) | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US5304595A (en) | 1988-11-21 | 1994-04-19 | Collagen Corporation | Collagen-polymer conjugates |
US5643464A (en) * | 1988-11-21 | 1997-07-01 | Collagen Corporation | Process for preparing a sterile, dry crosslinking agent |
US5475052A (en) | 1988-11-21 | 1995-12-12 | Collagen Corporation | Collagen-synthetic polymer matrices prepared using a multiple step reaction |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US5550187A (en) * | 1988-11-21 | 1996-08-27 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
DE3903672C1 (en) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
US5324844A (en) | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5141747A (en) | 1989-05-23 | 1992-08-25 | Minnesota Mining And Manufacturing Company | Denatured collagen membrane |
US5201764A (en) | 1990-02-28 | 1993-04-13 | Autogenesis Technologies, Inc. | Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom |
US5104957A (en) | 1990-02-28 | 1992-04-14 | Autogenesis Technologies, Inc. | Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom |
JP3210009B2 (en) | 1990-04-02 | 2001-09-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | Granular absorbent polymer composition containing interparticle crosslinked aggregates |
US5196027A (en) | 1990-05-02 | 1993-03-23 | Thompson Keith P | Apparatus and process for application and adjustable reprofiling of synthetic lenticules for vision correction |
US5204110A (en) * | 1990-05-02 | 1993-04-20 | Ndm Acquisition Corp. | High absorbency hydrogel wound dressing |
US5219564A (en) | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
US5292362A (en) | 1990-07-27 | 1994-03-08 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
US5209776A (en) | 1990-07-27 | 1993-05-11 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
SE466754B (en) | 1990-09-13 | 1992-03-30 | Berol Nobel Ab | COVALENT BINDING POLYMERS TO HYDROPHILIC SURFACES |
US5131875A (en) | 1990-10-12 | 1992-07-21 | Lee Warren D | Dual motor control and steering system for watercraft |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5626863A (en) | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5169754A (en) | 1990-10-31 | 1992-12-08 | Coulter Corporation | Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same |
US5163956A (en) | 1990-11-06 | 1992-11-17 | General Electric Company | Methods and lenticules for modifying the cornea |
US6559119B1 (en) * | 1990-11-27 | 2003-05-06 | Loyola University Of Chicago | Method of preparing a tissue sealant-treated biomedical material |
US5219895A (en) | 1991-01-29 | 1993-06-15 | Autogenesis Technologies, Inc. | Collagen-based adhesives and sealants and methods of preparation and use thereof |
US5156613A (en) | 1991-02-13 | 1992-10-20 | Interface Biomedical Laboratories Corp. | Collagen welding rod material for use in tissue welding |
US5208219A (en) | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
US5118667A (en) | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
JPH07503943A (en) | 1991-10-29 | 1995-04-27 | クローバー コンソリデイテッド,リミテッド | Cross-linked polysaccharides, polycations and lipids useful for encapsulation and drug release |
DE69229004D1 (en) | 1991-11-07 | 1999-05-27 | Univ Southern California | COMPOSITIONS AND METHODS FOR PREVENTING ADHESION FORMATION |
US5405366A (en) * | 1991-11-12 | 1995-04-11 | Nepera, Inc. | Adhesive hydrogels having extended use lives and process for the preparation of same |
US5147374A (en) * | 1991-12-05 | 1992-09-15 | Alfredo Fernandez | Prosthetic mesh patch for hernia repair |
US5176692A (en) * | 1991-12-09 | 1993-01-05 | Wilk Peter J | Method and surgical instrument for repairing hernia |
US5385606A (en) | 1992-07-06 | 1995-01-31 | Kowanko; Nicholas | Adhesive composition and method |
US5428022A (en) * | 1992-07-29 | 1995-06-27 | Collagen Corporation | Composition of low type III content human placental collagen |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5614549A (en) | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
AU675252B2 (en) * | 1992-12-18 | 1997-01-30 | Tremco, Inc. | Fast-curing, high strength, two-part sealants using acetoacetate-amine cure chemistry |
US5298643A (en) | 1992-12-22 | 1994-03-29 | Enzon, Inc. | Aryl imidate activated polyalkylene oxides |
US5349001A (en) | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
US5667839A (en) * | 1993-01-28 | 1997-09-16 | Collagen Corporation | Human recombinant collagen in the milk of transgenic animals |
US5321095A (en) | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
US5549904A (en) | 1993-06-03 | 1996-08-27 | Orthogene, Inc. | Biological adhesive composition and method of promoting adhesion between tissue surfaces |
FR2707878A1 (en) | 1993-07-21 | 1995-01-27 | Imedex | New adhesive compositions for surgical use. |
FR2707992B1 (en) * | 1993-07-21 | 1995-10-13 | Flamel Tech Sa | New organic products containing reactive thiol functions, one of their preparation processes and the biomaterials containing them. |
US5939385A (en) | 1993-08-13 | 1999-08-17 | Zymogenetics, Inc. | Transglutaminase cross-linkable polypeptides and methods relating thereto |
EP0724888B1 (en) * | 1993-09-16 | 2003-05-21 | Ogita Biomaterial Laboratories Co. Ltd. | Wound covering material and wound covering composition |
US5605976A (en) | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
EP0705298B1 (en) * | 1993-12-01 | 2002-03-27 | Bioartificial Gel Technologies Inc. | Albumin based hydrogel |
FR2715309B1 (en) | 1994-01-24 | 1996-08-02 | Imedex | Adhesive composition, for surgical use, based on collagen modified by oxidative cutting and not crosslinked. |
US5578661A (en) * | 1994-03-31 | 1996-11-26 | Nepera, Inc. | Gel forming system for use as wound dressings |
US5505952A (en) | 1994-04-19 | 1996-04-09 | United States Surgical Corporation | Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom |
US5583114A (en) * | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
FR2726571B1 (en) * | 1994-11-03 | 1997-08-08 | Izoret Georges | BIOLOGICAL GLUE, PREPARATION METHOD AND APPLICATION DEVICE FOR BIOLOGICAL GLUE, AND HARDENERS FOR BIOLOGICAL GLUE |
CA2167455A1 (en) * | 1995-01-19 | 1996-07-20 | Kevin Cooper | Absorbable polyalkylene diglycolates |
US5550172A (en) * | 1995-02-07 | 1996-08-27 | Ethicon, Inc. | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
US5464929A (en) * | 1995-03-06 | 1995-11-07 | Ethicon, Inc. | Absorbable polyoxaesters |
US5580923A (en) | 1995-03-14 | 1996-12-03 | Collagen Corporation | Anti-adhesion films and compositions for medical use |
US5900245A (en) * | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
US5612052A (en) * | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
US5817303A (en) * | 1995-05-05 | 1998-10-06 | Protein Polymer Technologies, Inc. | Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
JPH11506649A (en) * | 1995-06-06 | 1999-06-15 | クウォンティック バイオメディカル パートナーズ | Wound sealant preparation and application device and method |
US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
US5681904A (en) | 1996-04-01 | 1997-10-28 | Minnesota Mining And Manufacturing Company | Azido polymers having improved burn rate |
US5763589A (en) * | 1997-01-09 | 1998-06-09 | Incyte Pharmaceuticals, Inc. | Human membrane protein |
US5854382A (en) * | 1997-08-18 | 1998-12-29 | Meadox Medicals, Inc. | Bioresorbable compositions for implantable prostheses |
JP2001520979A (en) * | 1997-10-27 | 2001-11-06 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Methods and pharmaceutical compositions for retinal wound closure |
EP1137373A4 (en) | 1998-12-04 | 2004-05-19 | Chandrashekhar P Pathak | Biocompatible crosslinked polymers |
CA2359318C (en) | 1999-02-01 | 2009-06-30 | Donald Elbert | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
US6312725B1 (en) * | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
US6258124B1 (en) * | 1999-05-10 | 2001-07-10 | C. R. Bard, Inc. | Prosthetic repair fabric |
WO2001013884A2 (en) * | 1999-08-26 | 2001-03-01 | Basf Aktiengesellschaft | Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
DK1218437T3 (en) | 1999-08-27 | 2009-10-19 | Angiodevice Internat Gmbh | Preparations forming interpenetrating polymer networks for use as high-strength medical sealants |
EP1083184A3 (en) * | 1999-09-07 | 2002-07-17 | Basf Aktiengesellschaft | Silicon-containing polymers, their preparation and their use |
JP4227265B2 (en) | 1999-10-18 | 2009-02-18 | キヤノン株式会社 | Laser light quantity control device |
US6296607B1 (en) * | 2000-10-20 | 2001-10-02 | Praxis, Llc. | In situ bulking device |
US20030232013A1 (en) * | 2002-02-22 | 2003-12-18 | Gary Sieckman | Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides |
EP1364663A1 (en) * | 2002-05-21 | 2003-11-26 | Commonwealth Scientific And Industrial Research Organisation | Ocular devices with functionalized surface with adhesive properties |
-
2005
- 2005-04-28 CN CN201410276033.9A patent/CN104174071A/en active Pending
- 2005-04-28 BR BRPI0510477-7A patent/BRPI0510477B1/en active IP Right Grant
- 2005-04-28 WO PCT/US2005/015036 patent/WO2006078282A2/en active Application Filing
- 2005-04-28 KR KR1020107011113A patent/KR101148445B1/en active IP Right Grant
- 2005-04-28 US US11/118,088 patent/US8067031B2/en active Active
- 2005-04-28 WO PCT/US2005/014906 patent/WO2006083260A2/en active Application Filing
- 2005-04-28 CN CNA200580021739XA patent/CN101080246A/en active Pending
- 2005-04-28 KR KR1020067025027A patent/KR100974733B1/en active IP Right Grant
- 2005-04-28 NZ NZ550964A patent/NZ550964A/en unknown
-
2011
- 2011-10-24 US US13/279,982 patent/US8481073B2/en active Active
- 2011-10-24 US US13/279,987 patent/US8460708B2/en active Active
-
2015
- 2015-06-01 HK HK15105201.7A patent/HK1204584A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010003126A1 (en) * | 1995-10-05 | 2001-06-07 | Rhee Woonza M. | Method of making crosslinked polymer matrices in tissue treatment applications |
WO2002102864A1 (en) * | 2001-06-15 | 2002-12-27 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
WO2003080144A1 (en) * | 2002-03-22 | 2003-10-02 | Kuros Biosurgery Ag | Composition for hard tissue augmentation |
Also Published As
Publication number | Publication date |
---|---|
WO2006083260A2 (en) | 2006-08-10 |
KR20100061764A (en) | 2010-06-08 |
US20120041481A1 (en) | 2012-02-16 |
US8067031B2 (en) | 2011-11-29 |
BRPI0510477A (en) | 2008-01-08 |
KR100974733B1 (en) | 2010-08-06 |
HK1204584A1 (en) | 2015-11-27 |
CN101080246A (en) | 2007-11-28 |
CN104174071A (en) | 2014-12-03 |
KR20070033981A (en) | 2007-03-27 |
WO2006078282A2 (en) | 2006-07-27 |
US8481073B2 (en) | 2013-07-09 |
US20120039980A1 (en) | 2012-02-16 |
BRPI0510477B1 (en) | 2023-01-17 |
BRPI0510477A8 (en) | 2019-01-02 |
US8460708B2 (en) | 2013-06-11 |
WO2006078282A3 (en) | 2007-01-18 |
KR101148445B1 (en) | 2012-07-05 |
NZ550964A (en) | 2011-05-27 |
US20050281883A1 (en) | 2005-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006078282A3 (en) | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use | |
WO2006034128A3 (en) | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use | |
MX2010001219A (en) | Tunably crosslinked hyaluronic acid compositions. | |
WO2007016622A3 (en) | Gel composition for inhibiting cellular adhesion | |
WO2008098019A3 (en) | Polymer formulations for delivery of bioactive agents | |
WO2008054772A3 (en) | Implantable elastomeric caprolactone depot compositions and uses thereof | |
WO2004030617A3 (en) | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | |
WO2007140312A3 (en) | Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations | |
WO2007106457A3 (en) | Fluidic tissue augmentation compositions and methods | |
WO2007143726A3 (en) | Methods and compositons for tissue repair | |
NZ599527A (en) | Fragmented hydrogels | |
WO2002044276A3 (en) | Polyalkylene glycol viscosity-enhancing polymeric formulations | |
TW200503774A (en) | Controlled release depot formulations | |
WO2006052451A3 (en) | Implantable collagen compositions | |
WO2007019331A3 (en) | Conjugates of a g-csf moiety and a polymer | |
WO2006071649A3 (en) | Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chitosan | |
WO2006060235A3 (en) | Bioabsorbable, biobeneficial, tyrosine-based polymers for use in drug eluting stent coatings | |
WO2007089997A3 (en) | In-situ forming porous scaffold | |
WO2005099667A3 (en) | Drug delivery compositions | |
WO2009017646A3 (en) | Compositions comprising human collagen and human elastin and methods for soft tissue augmentation | |
EP2332590A3 (en) | Non-degradable low swelling, water soluble radiopaque hydrogels | |
WO2007056134A3 (en) | Resorbable phenolic polymers | |
WO2005002510A3 (en) | Deployable multifunctional hemostatic agent | |
MY144221A (en) | Biocompatible polymer compositions for dual or multistaged curing. | |
WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/012496 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 550964 Country of ref document: NZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067025027 Country of ref document: KR Ref document number: 06120218 Country of ref document: CO Ref document number: 4364/CHENP/2006 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067025027 Country of ref document: KR |
|
122 | Ep: pct application non-entry in european phase | ||
ENP | Entry into the national phase |
Ref document number: PI0510477 Country of ref document: BR |